CRISPR Therapeutics AG (CRSP)
71.46
-1.48
(-2.04%)
USD |
NASDAQ |
Mar 18, 16:00
71.89
+0.42
(+0.59%)
After-Hours: 20:00
CRISPR Therapeutics Price: 71.46 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 73.57 | 73.73 | 71.24 | 71.46 | 1.103M |
Mar 15, 2024 | 71.78 | 73.50 | 71.40 | 72.95 | 1.940M |
Mar 14, 2024 | 73.53 | 74.17 | 71.12 | 72.01 | 1.731M |
Mar 13, 2024 | 74.61 | 76.86 | 74.00 | 74.78 | 1.228M |
Mar 12, 2024 | 76.20 | 76.20 | 73.66 | 75.30 | 1.410M |
Mar 11, 2024 | 78.48 | 79.33 | 76.12 | 76.82 | 1.418M |
Mar 08, 2024 | 79.54 | 81.73 | 77.10 | 78.92 | 1.615M |
Mar 07, 2024 | 81.00 | 83.50 | 79.32 | 79.37 | 1.203M |
Mar 06, 2024 | 81.58 | 81.98 | 79.50 | 80.83 | 1.090M |
Mar 05, 2024 | 80.17 | 82.87 | 78.90 | 80.99 | 1.387M |
Mar 04, 2024 | 83.98 | 84.17 | 80.50 | 81.74 | 1.605M |
Mar 01, 2024 | 84.36 | 87.08 | 83.33 | 83.75 | 1.424M |
Feb 29, 2024 | 89.39 | 89.88 | 83.04 | 84.22 | 2.523M |
Feb 28, 2024 | 88.24 | 90.62 | 87.32 | 87.68 | 2.132M |
Feb 27, 2024 | 87.11 | 89.61 | 84.66 | 89.12 | 2.594M |
Feb 26, 2024 | 83.49 | 86.85 | 83.25 | 86.06 | 2.217M |
Feb 23, 2024 | 85.93 | 87.69 | 82.35 | 83.99 | 2.048M |
Feb 22, 2024 | 82.00 | 91.10 | 81.83 | 86.19 | 4.287M |
Feb 21, 2024 | 82.49 | 83.50 | 77.11 | 82.41 | 3.131M |
Feb 20, 2024 | 80.24 | 82.00 | 77.80 | 78.73 | 2.174M |
Feb 16, 2024 | 83.73 | 84.89 | 81.92 | 82.22 | 2.203M |
Feb 15, 2024 | 79.75 | 90.18 | 79.28 | 84.48 | 6.010M |
Feb 14, 2024 | 74.55 | 79.95 | 73.34 | 79.04 | 4.136M |
Feb 13, 2024 | 72.39 | 75.18 | 71.89 | 72.78 | 3.199M |
Feb 12, 2024 | 70.03 | 76.48 | 69.80 | 76.44 | 2.962M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
73.54
Average
62.69
Median
Jan 08 2024
Price Benchmarks
Vertex Pharmaceuticals Inc | 411.10 |
Intellia Therapeutics Inc | 27.37 |
Roche Holding AG | 32.18 |
Teladoc Health Inc | 15.12 |
Novartis AG | 95.92 |
Price Related Metrics
Price to Book Value | 3.047 |
Earnings Yield | -2.70% |
Market Cap | 5.737B |